Novel compounds open new research avenues for Alzheimer's disease therapeutics
February 24, 2026
February 24, 2026
NASHVILLE, Tennessee, Feb. 24 -- Vanderbilt University School of Medicine Basic Sciences issued the following news:
* * *
Novel compounds open new research avenues for Alzheimer's disease therapeutics
*
Alzheimer's disease is the most common cause of dementia, and it affects over seven million people in the United States alone. Although there are treatments that can slow its progression, most of them treat its symptoms only and none o . . .
* * *
Novel compounds open new research avenues for Alzheimer's disease therapeutics
*
Alzheimer's disease is the most common cause of dementia, and it affects over seven million people in the United States alone. Although there are treatments that can slow its progression, most of them treat its symptoms only and none o . . .